# Koppers Holdings Inc.: financial statements, quarterly

KOP · NYSE · CIK 1315257 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kop.md) · [Financials](/companies/kop/financials.md) · [Filings](/companies/kop/filings.md) · [Insiders](/companies/kop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [550](/filings/0000950170-24-123804.md) | [513 d](/filings/0001315257-26-000012.md) | [498](/filings/0000950170-25-067733.md) | [563](/filings/0000950170-25-105595.md) | [554](/filings/0001315257-25-000012.md) | [477 d](/filings/0001315257-26-000012.md) | [457](/filings/0001315257-26-000038.md) | [505](/filings/0001315257-26-000048.md) | [485](/filings/0001315257-25-000012.md) | [433 d](/filings/0001315257-26-000012.md) | [455](/filings/0001315257-26-000038.md) | [520](/filings/0001315257-26-000048.md) |
| Cost of revenue | $m | [439](/filings/0000950170-24-123804.md) | [417 d](/filings/0001315257-26-000012.md) | [401](/filings/0000950170-25-067733.md) | [442](/filings/0000950170-25-105595.md) | [433](/filings/0001315257-25-000012.md) | [393 d](/filings/0001315257-26-000012.md) | [351](/filings/0001315257-26-000038.md) | [391](/filings/0001315257-26-000048.md) | [368](/filings/0001315257-25-000012.md) | [322 d](/filings/0001315257-26-000012.md) | [369](/filings/0001315257-26-000038.md) | [411](/filings/0001315257-26-000048.md) |
| Selling, general and administrative | $m | [43.8](/filings/0000950170-24-123804.md) | [45.0 d](/filings/0001315257-26-000012.md) | [45.5](/filings/0000950170-25-067733.md) | [45.9](/filings/0000950170-25-105595.md) | [43.9](/filings/0001315257-25-000012.md) | [44.0 d](/filings/0001315257-26-000012.md) | [41.1](/filings/0001315257-26-000038.md) | [39.5](/filings/0001315257-26-000048.md) | [37.5](/filings/0001315257-25-000012.md) | [36.8 d](/filings/0001315257-26-000012.md) | [41.7](/filings/0001315257-26-000038.md) | [40.9](/filings/0001315257-26-000048.md) |
| Operating income | $m | [53.3](/filings/0000950170-24-123804.md) | [37.2 d](/filings/0001315257-26-000012.md) | [34.6](/filings/0000950170-25-067733.md) | [57.5](/filings/0000950170-25-105595.md) | [49.7](/filings/0001315257-25-000012.md) | [6.4 d](/filings/0001315257-26-000012.md) | [27.0](/filings/0001315257-26-000038.md) | [39.1](/filings/0001315257-26-000048.md) | [51.8](/filings/0001315257-25-000012.md) | [49.9 d](/filings/0001315257-26-000012.md) | [22.0](/filings/0001315257-26-000038.md) | [(166)](/filings/0001315257-26-000048.md) |
| Interest expense | $m | [19.0](/filings/0000950170-24-123804.md) | [17.7 d](/filings/0000950170-25-028542.md) | [17.1](/filings/0000950170-25-067733.md) | [20.6](/filings/0000950170-25-105595.md) | [20.2](/filings/0000950170-24-123804.md) | [18.3 d](/filings/0000950170-25-028542.md) | [16.6](/filings/0000950170-25-067733.md) | [17.3](/filings/0000950170-25-105595.md) | [16.7](/filings/0001315257-25-000012.md) | [15.5 d](/filings/0001315257-26-000012.md) | [15.0](/filings/0001315257-26-000038.md) | [15.0](/filings/0001315257-26-000048.md) |
| Income tax | $m | [8.3](/filings/0000950170-24-123804.md) | [6.7 d](/filings/0001315257-26-000012.md) | [4.4](/filings/0000950170-25-067733.md) | [10.2](/filings/0000950170-25-105595.md) | [10.6](/filings/0001315257-25-000012.md) | [(4.5) d](/filings/0001315257-26-000012.md) | [(3.3)](/filings/0001315257-26-000038.md) | [7.5](/filings/0001315257-26-000048.md) | [12.0](/filings/0001315257-25-000012.md) | [9.0 d](/filings/0001315257-26-000012.md) | [0.8](/filings/0001315257-26-000038.md) | [(32.5)](/filings/0001315257-26-000048.md) |
| Net income | $m | [26.3](/filings/0000950170-24-123804.md) | [12.9 d](/filings/0001315257-26-000012.md) | [13.0](/filings/0000950170-25-067733.md) | [26.8](/filings/0000950170-25-105595.md) | [22.8](/filings/0001315257-25-000012.md) | [(10.2) d](/filings/0001315257-26-000012.md) | [(13.9)](/filings/0001315257-26-000038.md) | [16.4](/filings/0001315257-26-000048.md) | [23.8](/filings/0001315257-25-000012.md) | [29.7 d](/filings/0001315257-26-000012.md) | [7.1](/filings/0001315257-26-000038.md) | [(148)](/filings/0001315257-26-000048.md) |
| Diluted EPS | $ per share | [1.22](/filings/0000950170-24-123804.md) | not reported | [0.59](/filings/0000950170-25-067733.md) | [1.25](/filings/0000950170-25-105595.md) | [1.09](/filings/0001315257-25-000012.md) | not reported | [(0.68)](/filings/0001315257-26-000038.md) | [0.81](/filings/0001315257-26-000048.md) | [1.17](/filings/0001315257-25-000012.md) | not reported | [0.35](/filings/0001315257-26-000038.md) | [(7.71)](/filings/0001315257-26-000048.md) |
| Basic EPS | $ per share | [1.27](/filings/0000950170-24-123804.md) | not reported | [0.61](/filings/0000950170-25-067733.md) | [1.29](/filings/0000950170-25-105595.md) | [1.12](/filings/0001315257-25-000012.md) | not reported | [(0.68)](/filings/0001315257-26-000038.md) | [0.83](/filings/0001315257-26-000048.md) | [1.21](/filings/0001315257-25-000012.md) | not reported | [0.36](/filings/0001315257-26-000038.md) | [(7.71)](/filings/0001315257-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [700](/filings/0000950170-23-058640.md) | [699](/filings/0000950170-25-028542.md) | [708](/filings/0000950170-24-052678.md) | [721](/filings/0000950170-24-093561.md) | [730](/filings/0000950170-24-123804.md) | [681](/filings/0001315257-26-000012.md) | [692](/filings/0000950170-25-067733.md) | [708](/filings/0000950170-25-105595.md) | [683](/filings/0001315257-25-000012.md) | [669](/filings/0001315257-26-000048.md) | [669](/filings/0001315257-26-000038.md) | [680](/filings/0001315257-26-000048.md) |
| Total assets | $m | [1,810](/filings/0000950170-23-058640.md) | [1,836](/filings/0000950170-25-028542.md) | [1,845](/filings/0000950170-24-052678.md) | [1,948](/filings/0000950170-24-093561.md) | [1,960](/filings/0000950170-24-123804.md) | [1,890](/filings/0001315257-26-000012.md) | [1,891](/filings/0000950170-25-067733.md) | [1,931](/filings/0000950170-25-105595.md) | [1,895](/filings/0001315257-25-000012.md) | [1,887](/filings/0001315257-26-000048.md) | [1,880](/filings/0001315257-26-000038.md) | [1,722](/filings/0001315257-26-000048.md) |
| Current liabilities | $m | [313](/filings/0000950170-23-058640.md) | [326](/filings/0000950170-25-028542.md) | [309](/filings/0000950170-24-052678.md) | [285](/filings/0000950170-24-093561.md) | [287](/filings/0000950170-24-123804.md) | [326](/filings/0001315257-26-000012.md) | [262](/filings/0000950170-25-067733.md) | [272](/filings/0000950170-25-105595.md) | [260](/filings/0001315257-25-000012.md) | [227](/filings/0001315257-26-000048.md) | [247](/filings/0001315257-26-000038.md) | [291](/filings/0001315257-26-000048.md) |
| Total liabilities | $m | [1,334](/filings/0000950170-23-058640.md) | [1,333](/filings/0000950170-25-028542.md) | [1,335](/filings/0000950170-24-052678.md) | [1,435](/filings/0000950170-24-093561.md) | [1,427](/filings/0000950170-24-123804.md) | [1,401](/filings/0001315257-26-000012.md) | [1,393](/filings/0000950170-25-067733.md) | [1,404](/filings/0000950170-25-105595.md) | [1,349](/filings/0001315257-25-000012.md) | [1,313](/filings/0001315257-26-000048.md) | [1,331](/filings/0001315257-26-000038.md) | [1,335](/filings/0001315257-26-000048.md) |
| Long-term debt | $m | [860](/filings/0000950170-23-058640.md) | [835](/filings/0000950170-25-028542.md) | [865](/filings/0000950170-24-052678.md) | [987](/filings/0000950170-24-093561.md) | [976](/filings/0000950170-24-123804.md) | [926](/filings/0001315257-26-000012.md) | [976](/filings/0000950170-25-067733.md) | [963](/filings/0000950170-25-105595.md) | [918](/filings/0001315257-25-000012.md) | [914](/filings/0001315257-26-000048.md) | [915](/filings/0001315257-26-000038.md) | [893](/filings/0001315257-26-000048.md) |
| Current portion of debt | $m | [4.0](/filings/0000950170-23-058640.md) | [5.0](/filings/0000950170-25-028542.md) | [4.0](/filings/0000950170-24-052678.md) | [5.0](/filings/0000950170-24-093561.md) | [5.0](/filings/0000950170-24-123804.md) | [4.9](/filings/0001315257-26-000012.md) | [4.9](/filings/0000950170-25-067733.md) | [4.9](/filings/0000950170-25-105595.md) | [4.9](/filings/0001315257-25-000012.md) | [4.9](/filings/0001315257-26-000048.md) | [4.9](/filings/0001315257-26-000038.md) | [4.9](/filings/0001315257-26-000048.md) |
| Shareholders' equity | $m | [472](/filings/0000950170-23-058640.md) | [499](/filings/0000950170-25-028542.md) | [506](/filings/0000950170-24-052678.md) | [509](/filings/0000950170-24-093561.md) | [532](/filings/0000950170-24-123804.md) | [489](/filings/0001315257-26-000012.md) | [498](/filings/0000950170-25-067733.md) | [527](/filings/0000950170-25-105595.md) | [546](/filings/0001315257-25-000012.md) | [574](/filings/0001315257-26-000048.md) | [550](/filings/0001315257-26-000038.md) | [387](/filings/0001315257-26-000048.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [81.6 d](/filings/0000950170-24-123804.md) | [66.6 d](/filings/0001315257-26-000012.md) | [(12.3)](/filings/0000950170-25-067733.md) | [27.2 d](/filings/0000950170-25-105595.md) | [29.8 d](/filings/0001315257-25-000012.md) | [74.7 d](/filings/0001315257-26-000012.md) | [(22.7)](/filings/0001315257-26-000038.md) | [50.5 d](/filings/0001315257-26-000048.md) | [49.6 d](/filings/0001315257-25-000012.md) | [45.1 d](/filings/0001315257-26-000012.md) | [46.3](/filings/0001315257-26-000038.md) | [50.0 d](/filings/0001315257-26-000048.md) |
| Capital expenditure | $m | [28.7 d](/filings/0000950170-24-123804.md) | [29.2 d](/filings/0001315257-26-000012.md) | [26.3](/filings/0000950170-25-067733.md) | [17.1](/filings/0000950170-25-105595.md) | [15.4](/filings/0001315257-25-000012.md) | [18.6 d](/filings/0001315257-26-000012.md) | [14.3](/filings/0001315257-26-000038.md) | [12.1](/filings/0000950170-25-105595.md) | [12.0](/filings/0001315257-25-000012.md) | [16.6 d](/filings/0001315257-26-000012.md) | [11.4](/filings/0001315257-26-000038.md) | [12.3 d](/filings/0001315257-26-000048.md) |
| Dividends paid | $m | [1.3 d](/filings/0000950170-24-123804.md) | [1.2 d](/filings/0001315257-26-000012.md) | [1.5](/filings/0000950170-25-067733.md) | [1.6 d](/filings/0000950170-25-105595.md) | [1.5 d](/filings/0001315257-25-000012.md) | [1.3 d](/filings/0001315257-26-000012.md) | [1.6](/filings/0001315257-26-000038.md) | [1.6 d](/filings/0001315257-26-000048.md) | [1.5 d](/filings/0001315257-25-000012.md) | [1.7 d](/filings/0001315257-26-000012.md) | [2.2](/filings/0001315257-26-000038.md) | [1.6 d](/filings/0001315257-26-000048.md) |
| Share repurchases | $m | [3.9 d](/filings/0000950170-24-123804.md) | [10.3 d](/filings/0001315257-26-000012.md) | [6.9](/filings/0000950170-25-067733.md) | [32.2 d](/filings/0000950170-25-105595.md) | [10.4 d](/filings/0001315257-25-000012.md) | [1.3 d](/filings/0001315257-26-000012.md) | [19.1](/filings/0001315257-26-000038.md) | [10.1 d](/filings/0001315257-26-000048.md) | [4.1 d](/filings/0001315257-25-000012.md) | [4.9 d](/filings/0001315257-26-000012.md) | [29.0](/filings/0001315257-26-000038.md) | [14.9 d](/filings/0001315257-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.1](/filings/0000950170-23-058640.md) | [21.4](/filings/0000950170-24-052678.md) | [21.4](/filings/0000950170-24-093561.md) | [21.7](/filings/0000950170-24-123804.md) | [21.9](/filings/0000950170-25-067733.md) | [21.6](/filings/0000950170-25-105595.md) | [21.0](/filings/0001315257-25-000012.md) | [20.4](/filings/0001315257-26-000038.md) | [20.2](/filings/0001315257-26-000048.md) | [20.2](/filings/0001315257-25-000012.md) | [20.1](/filings/0001315257-26-000038.md) | [19.1](/filings/0001315257-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,911,568 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001315257-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.